- Home
- UPWK vs ATTO Comparison
UPWK vs ATTO Comparison
Compare UPWK & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UPWK | ATTO |
|---|---|---|
| Founded | 1998 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2018 | 2026 |
Fundamental Metrics
Financial Performance| Metric | UPWK | ATTO |
|---|---|---|
| Price | $8.36 | $17.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | $9.88 | ★ $42.20 |
| AVG Volume (30 Days) | ★ 2.4M | 333.4K |
| Earning Date | 11-02-2026 | 09-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.44 | N/A |
| Revenue | ★ $787,784,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.02 | ★ N/A |
| Revenue Growth | ★ 2.40 | N/A |
| 52 Week Low | $7.44 | $16.15 |
| 52 Week High | $22.84 | $28.00 |
Technical Indicators
Market Signals| Indicator | UPWK | ATTO |
|---|---|---|
| Relative Strength Index (RSI) | 46.71 | 39.32 |
| Support Level | $8.29 | $16.39 |
| Resistance Level | $9.36 | $24.89 |
| Average True Range (ATR) | 0.25 | 1.91 |
| MACD | 0.01 | -0.47 |
| Stochastic Oscillator | 56.91 | 14.82 |
Price Performance
Historical ComparisonAbout UPWK Upwork Inc.
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes and connects businesses with AI-enabled talent across every on-demand work type, including freelance, agency, fractional, and payrolled. The business generates revenue from Talent and Clients across the USA, India, Pakistan, the Philippines and the rest of the world. Maximum revenue of the company is derived from Talent segment.
About ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.